Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity? [10]

Histopathology

Volumn 49, Issue 5, 2006, Pages 557-558

  Kayasut, K ^a   Le Tourneau, A ^b   Rio, B ^c   Bost Bezeaud, F ^d   Heuberger, L ^e   Diebold, J ^b   Audouin, J ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Service Central d'Anatomie et de Cytologie Pathologiques   (France)

^c HÔTEL DIEU   (France)

^d Laboratoires de Biologie et de Pathologie

^e Centre IRD Papeete   (French Polynesia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

AGED; ANAMNESIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; HUMAN; INGUINAL LYMPH NODE; LABORATORY TEST; LETTER; LYMPH NODE BIOPSY; MALE; PHYSICAL EXAMINATION; PLASMACYTOSIS; PRIORITY JOURNAL; SEROLOGY; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; PLASMA CELLS; PLASMACYTOMA; PREDNISOLONE; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33750305112     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02532.x     Document Type: Letter

References (12)

1. Diebold J, Tulliez M, Bernadou A et al. Angiofollicular and plasmacytic polyadenopathy: a pseudotumourous syndrome with dysimmunity. J. Clin. Pathol. 1980; 33; 1068-1076.
2. Frizzera G, Peterson BA, Bayrd ED et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J. Clin. Oncol. 1985; 3; 1202-1216.
3. Kubota Y, Noto S, Takakuwa T et al. Skin involvement in giant lymph node hyperplasia (Castleman's disease). J. Am. Acad. Dermatol. 1993; 29; 778-780.
4. Skelton HG, Smith KJ. Extranodal multicentric Castleman's disease with cutaneous involvement. Mod. Pathol. 1998; 11; 93-98.
5. Watanabe S, Ohara K, Kukita A et al. Systemic plasmacytosis. A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia. Arch. Dermatol. 1986; 122; 1314-1320.
6. Leger-Ravet MB, Peuchmaur M, Devergne O et al. Interleukin-6 gene expression in Castleman's disease. Blood 1991; 78; 2923-2930.
7. Kodama A, Tani M, Hori K et al. Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels. Br. J. Dermatol. 1992; 127; 49-53.
8. Kanabe N, Kurosawa M, Akimoto S et al. Systemic plasmacytosis with deposition of interleukin (IL)-6 and elevated expression of IL-6 mRNA in the skin lesions. Br. J. Dermatol. 1998; 138; 721-723.
9. Soulier J, Grollet L, Oksenhendler E et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86; 1276-1280.
10. Gessain A, Sudaka A, Briere J et al. Kaposi sarcoma-associated herpes-like virus (human herpervirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87; 414-416.
11. Watanabe T, Tada Y, Nakanura K et al. Failure to detect human herpesvirus type 8-DNA sequences in systemic plasmacytosis from HIV-uninfected Japanese patients. Br. J. Dermatol. 1999; 141; 360-361.
12. Okada H, Kano R, Watanabe S. Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with systemic plasmacytosis. Br. J. Dermatol. 1999; 141; 942-943.